We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$710M
2
JNJ icon
Johnson & Johnson
JNJ
+$574M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M
4
MRVL icon
Marvell Technology
MRVL
+$377M
5
WFC icon
Wells Fargo
WFC
+$333M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXPD icon
2001
Expeditors International
EXPD
$23.7B
$2K ﹤0.01%
+24
New +$2.86K
GRVY
2002
GRAVITY
GRVY
$432M
$2K ﹤0.01%
42
– –
ISSC icon
2003
Innovative Solutions & Support
ISSC
$370M
$2K ﹤0.01%
310
-75
-19% -$562
JCI icon
2004
Johnson Controls International
JCI
$93.1B
$2K ﹤0.01%
38
-329
-90% -$26.4K
MSM icon
2005
MSC Industrial Direct
MSM
$7.01B
$2K ﹤0.01%
32
– –
OPEN icon
2006
Opendoor
OPEN
$3.63B
$2K ﹤0.01%
1,705
-1,158
-40% -$2.1K
PCYO icon
2007
Pure Cycle
PCYO
$255M
$2K ﹤0.01%
+228
New +$2.78K
PLX icon
2008
Protalix BioTherapeutics
PLX
$197M
$2K ﹤0.01%
+1,255
New +$1.77K
PSFE icon
2009
Paysafe
PSFE
$412M
$2K ﹤0.01%
161
+125
+347% +$2.53K
RDFN
2010
DELISTED
Redfin
RDFN
$2K ﹤0.01%
368
+216
+142% +$2.1K
RERE
2011
ATRenew
RERE
$966M
$2K ﹤0.01%
+943
New +$2.62K
RPD icon
2012
Rapid7
RPD
$726M
$2K ﹤0.01%
54
– –
SCLX icon
2013
Scilex Holding
SCLX
$45.9M
$2K ﹤0.01%
162
-31
-16% -$788
USB icon
2014
US Bancorp
USB
$100B
$2K ﹤0.01%
58
+3
+5% +$148
WBA
2015
DELISTED
Walgreens Boots Alliance
WBA
$2K ﹤0.01%
+285
New +$2.65K
WVE icon
2016
Wave Life Sciences
WVE
$1.17B
$2K ﹤0.01%
217
– –
PTVE
2017
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$2K ﹤0.01%
133
-33,145
-100% -$448K
AZPN
2018
DELISTED
Aspen Technology Inc
AZPN
$2K ﹤0.01%
10
-565,773
-100% -$138M
ML
2019
DELISTED
MoneyLion Inc.
ML
$2K ﹤0.01%
+34
New +$2.29K
AENT icon
2020
Alliance Entertainment
AENT
$284M
$1K ﹤0.01%
+148
New +$704
AHCO icon
2021
AdaptHealth
AHCO
$884M
$1K ﹤0.01%
160
-145
-48% -$1.47K
ALB icon
2022
Albemarle
ALB
$14B
$1K ﹤0.01%
13
– –
ALLY icon
2023
Ally Financial
ALLY
$13.6B
$1K ﹤0.01%
31
-1,515
-98% -$55K
ARES icon
2024
Ares Management
ARES
$31.5B
$1K ﹤0.01%
8
– –
BIO icon
2025
Bio-Rad Laboratories Class A
BIO
$9.31B
$1K ﹤0.01%
4
– –
79 80
81
82 83

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.